We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CNO Financial's Washington National Enhances Insurance Product
Read MoreHide Full Article
CNO Financial Group, Inc.’s (CNO - Free Report) brand, Washington National Insurance Company, recently unveiled its enhanced Hospital Indemnity Insurance product in a bid to provide additional benefits to consumer and worksite customers. This move by CNO Financial enhances its offerings for middle-income Americans, who are increasingly vulnerable to rising healthcare costs.
This move bodes well, as by adding coverage for mental illness and offering cash benefits for both inpatient and outpatient care, the product is designed to address the growing need for healthcare coverage. With nearly half of U.S. adults unable to cover unexpected medical bills of $500 without resorting to debt, this product would provide financial relief. Optional riders on top of base coverage enable customization, making it an attractive option for consumers seeking flexibility.
This enhanced product positions CNO to capture additional market share within the worksite and individual customer divisions. CNO is undertaking initiatives such as enhancing offerings and rolling out new products to deliver solid sales growth. Increased adoption of the plan could lead to higher premiums earned and customer retention. Benefits of the enhanced product include portability, renewability, consistency and flexibility.
This is a time-opportune move on the part of CNO, as the demand for supplemental insurance grows in response to rising healthcare costs. Moves like these should aid CNO achieve its 2024 earnings per share target in the range of $3.30-$3.50. CNO is resorting to programs to drive sales growth like adding new products and geographic expansions.
CNO’s Zacks Rank & Price Performance
CNO Financial currently carries a Zacks Rank #3 (Hold).
Shares of the company have gained 26.5% in the past three months compared with the industry’s 5.8% rise.
Image Source: Zacks Investment Research
Stocks to Consider
Investors interested in the broader Finance space may look at some better-ranked players like MGIC Investment Corporation (MTG - Free Report) , Jackson Financial Inc. (JXN - Free Report) and WisdomTree, Inc. (WT - Free Report) . While MGIC Investment currently sports a Zacks Rank #1 (Strong Buy), Jackson Financial and WisdomTree carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for MGIC Investment’s current-year earnings suggests a 9.1% year-over-year increase. During the past month, MTG has witnessed one upward estimate revision against none in the opposite direction. The consensus mark for current-year revenues is pegged at $1.2 billion, indicating a 4.7% increase from a year ago.
The Zacks Consensus Estimate for Jackson Financial’s current-year earnings is pegged at $18.49 per share, which indicates 44% year-over-year growth. It witnessed two upward estimate revisions in the past 60 days against no downward movement. The consensus mark for JXN’s current-year revenues suggests a 116.7% surge from a year ago.
The Zacks Consensus Estimate for WisdomTree’s 2024 earnings indicates 67.6% year-over-year growth. During the past month, WT has witnessed two upward estimate revisions against none in the opposite direction. It beat earnings estimates twice in the past four quarters and met on the other occasions, with an average surprise of 5.9%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
CNO Financial's Washington National Enhances Insurance Product
CNO Financial Group, Inc.’s (CNO - Free Report) brand, Washington National Insurance Company, recently unveiled its enhanced Hospital Indemnity Insurance product in a bid to provide additional benefits to consumer and worksite customers. This move by CNO Financial enhances its offerings for middle-income Americans, who are increasingly vulnerable to rising healthcare costs.
This move bodes well, as by adding coverage for mental illness and offering cash benefits for both inpatient and outpatient care, the product is designed to address the growing need for healthcare coverage. With nearly half of U.S. adults unable to cover unexpected medical bills of $500 without resorting to debt, this product would provide financial relief. Optional riders on top of base coverage enable customization, making it an attractive option for consumers seeking flexibility.
This enhanced product positions CNO to capture additional market share within the worksite and individual customer divisions. CNO is undertaking initiatives such as enhancing offerings and rolling out new products to deliver solid sales growth. Increased adoption of the plan could lead to higher premiums earned and customer retention. Benefits of the enhanced product include portability, renewability, consistency and flexibility.
This is a time-opportune move on the part of CNO, as the demand for supplemental insurance grows in response to rising healthcare costs. Moves like these should aid CNO achieve its 2024 earnings per share target in the range of $3.30-$3.50. CNO is resorting to programs to drive sales growth like adding new products and geographic expansions.
CNO’s Zacks Rank & Price Performance
CNO Financial currently carries a Zacks Rank #3 (Hold).
Shares of the company have gained 26.5% in the past three months compared with the industry’s 5.8% rise.
Image Source: Zacks Investment Research
Stocks to Consider
Investors interested in the broader Finance space may look at some better-ranked players like MGIC Investment Corporation (MTG - Free Report) , Jackson Financial Inc. (JXN - Free Report) and WisdomTree, Inc. (WT - Free Report) . While MGIC Investment currently sports a Zacks Rank #1 (Strong Buy), Jackson Financial and WisdomTree carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for MGIC Investment’s current-year earnings suggests a 9.1% year-over-year increase. During the past month, MTG has witnessed one upward estimate revision against none in the opposite direction. The consensus mark for current-year revenues is pegged at $1.2 billion, indicating a 4.7% increase from a year ago.
The Zacks Consensus Estimate for Jackson Financial’s current-year earnings is pegged at $18.49 per share, which indicates 44% year-over-year growth. It witnessed two upward estimate revisions in the past 60 days against no downward movement. The consensus mark for JXN’s current-year revenues suggests a 116.7% surge from a year ago.
The Zacks Consensus Estimate for WisdomTree’s 2024 earnings indicates 67.6% year-over-year growth. During the past month, WT has witnessed two upward estimate revisions against none in the opposite direction. It beat earnings estimates twice in the past four quarters and met on the other occasions, with an average surprise of 5.9%.